News

September 17, 2015

Cure SMA Awards $150,000 to Dr. Lee Rubin at Harvard to Advance a New SMA Drug Discovery Program

Originally published on January 18, 2013.

Cure SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy by funding and advancing a comprehensive research program, including drug discovery programs to make practical new therapies.   Dr. Rubin's project at Harvard University is the first of...

READ MORE   |  

Topics: Archives

September 17, 2015

Cure SMA and Nationwide Children’s Announce Multi-Million Dollar Award from NINDS to Advance CNS Gene Therapy for Spinal Muscular Atrophy

Originally published on March 13, 2013.

Nationwide Children’s Hospital (Columbus, OH) and Cure Spinal Muscular Atrophy (Elk Grove Village, IL) announce the award of a multi-million dollar cooperative agreement from the National Institute of Neurological Disorders and Stroke (NINDS) to advance a gene therapy...

READ MORE   |  

Topics: Archives

September 17, 2015

Pfizer Licenses Cure SMA Quinazoline Drug Program from Repligen

Originally published on January 3, 2013.

Repligen Corporation announced today that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. to advance Repligen’s spinal muscular atrophy (SMA) program, originally in-licensed from Cure SMA.

Cure SMA funded and directed the preclinical...

READ MORE   |  

Topics: Archives

Items 1 - 3 of 82  12345678910Next

© 2014 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software